PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.\', \'Department of Neurology and Department of Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.\', \'Laboratorio di Malattie Neurologiche, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.\', \'Department of Neurology, Neurocritical Care Unit, Medical University of Innsbruck, Innsbruck, Austria.\', \'Division of Neurology, Centre Hospitalier Universitaire of Grenoble, Grenoble Alpes University, Grenoble Institute of Neuroscience, Grenoble, France.\', \'Division of Cancer Epidemiology and Genetics, National Cancer Institute, Baltimore, Maryland.\', \'Department of Neurology, The Ohio State University, Columbus.\', \'Department of Neurology, University of Bern, Inselspital, Bern, Switzerland.\', \'Departments of Anesthesiology and Critical Care Medicine, Neurology, and Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland.\', \'College of Nursing, The Ohio State University, Columbus.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jamanetworkopen.2021.12131
?:hasPublicationType
?:journal
  • JAMA network open
is ?:pmid of
?:pmid
?:pmid
  • 33974053
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all